炎症性腸疾患の世界市場 2023-2027

炎症性腸疾患市場は2022-2027年に76億8,743万米ドル、予測期間中のCAGRは5.77%で成長すると予測されています。

当レポートでは、炎症性腸疾患市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。IBD市場は、世界のIBD罹患率の増加、生物学的製剤や標的治療薬に対する需要の増加、IBDに対する意識の高まりが牽引しています。

本調査では、IBD治療薬の新規上市が、今後数年間の炎症性腸疾患市場成長を牽引する主要因の一つであると特定しています。また、IBD関連の調査研究への資金提供や、世界のIBD市場におけるM&Aは、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 炎症性腸疾患の世界市場 2017-2021
• 流通チャネルセグメント分析 2017-2021
• タイプセグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• オフライン：市場規模と予測 2022-2027
• オンライン：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第7章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• クローン病：市場規模と予測 2022-2027
• 潰瘍性大腸炎：市場規模と予測 2022-2027
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• インド：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AstraZeneca
• Aurobindo Pharma Ltd.
• Baxter International Inc.
• Bayer AG
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global inflammatory bowel disease market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Distribution Channel ($ million)
• Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits44: Chart on Type - Market share 2022-2027 (%)
• Exhibits45: Data Table on Type - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Type
• Exhibits47: Data Table on Comparison by Type
• Exhibits48: Chart on Crohn disease - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Crohn disease - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Crohn disease - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Crohn disease - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
• Exhibits56: Market opportunity by Type ($ million)
• Exhibits57: Data Table on Market opportunity by Type ($ million)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on India - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on India - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on India - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ million)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits101: Impact of drivers and challenges in 2022 and 2027
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: AstraZeneca - Overview
• Exhibits108: AstraZeneca - Product / Service
• Exhibits109: AstraZeneca - Key news
• Exhibits110: AstraZeneca - Key offerings
• Exhibits111: Aurobindo Pharma Ltd. - Overview
• Exhibits112: Aurobindo Pharma Ltd. - Product / Service
• Exhibits113: Aurobindo Pharma Ltd. - Key offerings
• Exhibits114: Baxter International Inc. - Overview
• Exhibits115: Baxter International Inc. - Business segments
• Exhibits116: Baxter International Inc. - Key news
• Exhibits117: Baxter International Inc. - Key offerings
• Exhibits118: Baxter International Inc. - Segment focus
• Exhibits119: Bayer AG - Overview
• Exhibits120: Bayer AG - Business segments
• Exhibits121: Bayer AG - Key news
• Exhibits122: Bayer AG - Key offerings
• Exhibits123: Bayer AG - Segment focus
• Exhibits124: Eli Lilly and Co. - Overview
• Exhibits125: Eli Lilly and Co. - Product / Service
• Exhibits126: Eli Lilly and Co. - Key news
• Exhibits127: Eli Lilly and Co. - Key offerings
• Exhibits128: F. Hoffmann La Roche Ltd. - Overview
• Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits130: F. Hoffmann La Roche Ltd. - Key news
• Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits133: GlaxoSmithKline Plc - Overview
• Exhibits134: GlaxoSmithKline Plc - Business segments
• Exhibits135: GlaxoSmithKline Plc - Key news
• Exhibits136: GlaxoSmithKline Plc - Key offerings
• Exhibits137: GlaxoSmithKline Plc - Segment focus
• Exhibits138: Johnson and Johnson Services Inc. - Overview
• Exhibits139: Johnson and Johnson Services Inc. - Business segments
• Exhibits140: Johnson and Johnson Services Inc. - Key news
• Exhibits141: Johnson and Johnson Services Inc. - Key offerings
• Exhibits142: Johnson and Johnson Services Inc. - Segment focus
• Exhibits143: Merck and Co. Inc. - Overview
• Exhibits144: Merck and Co. Inc. - Business segments
• Exhibits145: Merck and Co. Inc. - Key news
• Exhibits146: Merck and Co. Inc. - Key offerings
• Exhibits147: Merck and Co. Inc. - Segment focus
• Exhibits148: Novartis AG - Overview
• Exhibits149: Novartis AG - Business segments
• Exhibits150: Novartis AG - Key offerings
• Exhibits151: Novartis AG - Segment focus
• Exhibits152: Pfizer Inc. - Overview
• Exhibits153: Pfizer Inc. - Product / Service
• Exhibits154: Pfizer Inc. - Key news
• Exhibits155: Pfizer Inc. - Key offerings
• Exhibits156: Sanofi - Overview
• Exhibits157: Sanofi - Business segments
• Exhibits158: Sanofi - Key news
• Exhibits159: Sanofi - Key offerings
• Exhibits160: Sanofi - Segment focus
• Exhibits161: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits162: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits163: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits169: Viatris Inc. - Overview
• Exhibits170: Viatris Inc. - Business segments
• Exhibits171: Viatris Inc. - Key news
• Exhibits172: Viatris Inc. - Key offerings
• Exhibits173: Viatris Inc. - Segment focus
• Exhibits174: Inclusions checklist
• Exhibits175: Exclusions checklist
• Exhibits176: Currency conversion rates for US$
• Exhibits177: Research methodology
• Exhibits178: Validation techniques employed for market sizing
• Exhibits179: Information sources
• Exhibits180: List of abbreviations

The inflammatory bowel disease market is forecasted to grow by USD 7687.43 mn during 2022-2027, accelerating at a CAGR of 5.77% during the forecast period. The report on the inflammatory bowel disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of IBD worldwide, increasing demand for biologics and targeted therapies, and increasing awareness of IBD.

Technavio's inflammatory bowel disease market is segmented as below:

By Distribution Channel

• Offline
• Online

By Type

• Crohn disease
• Ulcerative colitis

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the new launches of IBD therapeutics as one of the prime reasons driving the inflammatory bowel disease market growth during the next few years. Also, funding for ibd-related research studies and mergers and acquisitions in the global IBD market will lead to sizable demand in the market.

The report on the inflammatory bowel disease market covers the following areas:

• Inflammatory bowel disease market sizing
• Inflammatory bowel disease market forecast
• Inflammatory bowel disease market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading inflammatory bowel disease market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca, Aurobindo Pharma Ltd., Bausch Health Co. Inc., Baxter International Inc., Bayer AG, Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Johnson and Johnson Services Inc.. Also, the inflammatory bowel disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global inflammatory bowel disease market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global inflammatory bowel disease market 2017 - 2021 ($ million)
• 4.2 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Offline - Market size and forecast 2022-2027
• Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• 6.4 Online - Market size and forecast 2022-2027
• Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Distribution Channel
• Exhibit 42: Market opportunity by Distribution Channel ($ million)
• Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 44: Chart on Type - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 46: Chart on Comparison by Type
• Exhibit 47: Data Table on Comparison by Type
• 7.3 Crohn disease - Market size and forecast 2022-2027
• Exhibit 48: Chart on Crohn disease - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Crohn disease - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Crohn disease - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Crohn disease - Year-over-year growth 2022-2027 (%)
• 7.4 Ulcerative colitis - Market size and forecast 2022-2027
• Exhibit 52: Chart on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Type
• Exhibit 56: Market opportunity by Type ($ million)
• Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 China - Market size and forecast 2022-2027
• Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 India - Market size and forecast 2022-2027
• Exhibit 91: Chart on India - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on India - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on India - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 AstraZeneca
• Exhibit 107: AstraZeneca - Overview
• Exhibit 108: AstraZeneca - Product / Service
• Exhibit 109: AstraZeneca - Key news
• Exhibit 110: AstraZeneca - Key offerings
• 12.4 Aurobindo Pharma Ltd.
• Exhibit 111: Aurobindo Pharma Ltd. - Overview
• Exhibit 112: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 113: Aurobindo Pharma Ltd. - Key offerings
• 12.5 Baxter International Inc.
• Exhibit 114: Baxter International Inc. - Overview
• Exhibit 115: Baxter International Inc. - Business segments
• Exhibit 116: Baxter International Inc. - Key news
• Exhibit 117: Baxter International Inc. - Key offerings
• Exhibit 118: Baxter International Inc. - Segment focus
• 12.6 Bayer AG
• Exhibit 119: Bayer AG - Overview
• Exhibit 120: Bayer AG - Business segments
• Exhibit 121: Bayer AG - Key news
• Exhibit 122: Bayer AG - Key offerings
• Exhibit 123: Bayer AG - Segment focus
• 12.7 Eli Lilly and Co.
• Exhibit 124: Eli Lilly and Co. - Overview
• Exhibit 125: Eli Lilly and Co. - Product / Service
• Exhibit 126: Eli Lilly and Co. - Key news
• Exhibit 127: Eli Lilly and Co. - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 GlaxoSmithKline Plc
• Exhibit 133: GlaxoSmithKline Plc - Overview
• Exhibit 134: GlaxoSmithKline Plc - Business segments
• Exhibit 135: GlaxoSmithKline Plc - Key news
• Exhibit 136: GlaxoSmithKline Plc - Key offerings
• Exhibit 137: GlaxoSmithKline Plc - Segment focus
• 12.10 Johnson and Johnson Services Inc.
• Exhibit 138: Johnson and Johnson Services Inc. - Overview
• Exhibit 139: Johnson and Johnson Services Inc. - Business segments
• Exhibit 140: Johnson and Johnson Services Inc. - Key news
• Exhibit 141: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 142: Johnson and Johnson Services Inc. - Segment focus
• 12.11 Merck and Co. Inc.
• Exhibit 143: Merck and Co. Inc. - Overview
• Exhibit 144: Merck and Co. Inc. - Business segments
• Exhibit 145: Merck and Co. Inc. - Key news
• Exhibit 146: Merck and Co. Inc. - Key offerings
• Exhibit 147: Merck and Co. Inc. - Segment focus
• 12.12 Novartis AG
• Exhibit 148: Novartis AG - Overview
• Exhibit 149: Novartis AG - Business segments
• Exhibit 150: Novartis AG - Key offerings
• Exhibit 151: Novartis AG - Segment focus
• 12.13 Pfizer Inc.
• Exhibit 152: Pfizer Inc. - Overview
• Exhibit 153: Pfizer Inc. - Product / Service
• Exhibit 154: Pfizer Inc. - Key news
• Exhibit 155: Pfizer Inc. - Key offerings
• 12.14 Sanofi
• Exhibit 156: Sanofi - Overview
• Exhibit 157: Sanofi - Business segments
• Exhibit 158: Sanofi - Key news
• Exhibit 159: Sanofi - Key offerings
• Exhibit 160: Sanofi - Segment focus
• 12.15 Sun Pharmaceutical Industries Ltd.
• Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Viatris Inc.
• Exhibit 169: Viatris Inc. - Overview
• Exhibit 170: Viatris Inc. - Business segments
• Exhibit 171: Viatris Inc. - Key news
• Exhibit 172: Viatris Inc. - Key offerings
• Exhibit 173: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 174: Inclusions checklist
• Exhibit 175: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 176: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 177: Research methodology
• Exhibit 178: Validation techniques employed for market sizing
• Exhibit 179: Information sources
• 13.5 List of abbreviations
• Exhibit 180: List of abbreviations